Found 7 matching trials
PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma
PHASE1Single center, phase I/II randomized 2-arm study, evaluating two different ...
Location
Multiple Locations
Dendritic Cell Based Therapy of Malignant Melanoma
PHASE1The aim of the study is to show if vaccination with autologous dendritic ce...
Location
Department of Oncology, Copenhagen University Hospital, Herlev
Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
PHASE1This phase I trial studies the side effects and how well of pembrolizumab a...
Status
Active Not Recruiting
Dendritic Cell-based Immunotherapy in Mesothelioma
PHASE1Exploiting the immunostimulatory capacities of dendritic cells holds great ...
Location
Department of Pulmonary Medicine
Dendritic Cell Based Therapy of Renal Cell Carcinoma
PHASE1The purpose of this study is to show if vaccination with autologous dendrit...
Location
Department of Oncology, Copenhagen University Hospital, Herlev
Dendritic Cell Vaccine for Patients With Brain Tumors
PHASE2The main purpose of this study is to evaluate the most effective immunother...
Location
University of Los Angeles, California
Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma
PHASE1Earlier the investigators determined the safety and feasibility of tumor ly...
Location
Erasmus Medical Center